(Q37260395)

English

A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis

scientific article published on 04 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

0 references

1 reference

Europe PubMed Central

A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Mohammad Abdollahi

object named as

Mohammad Abdollahi

4

0 references

object named as

Roja Rahimi

2

0 references

author name string

Shekoufeh Nikfar

1

1 reference

Europe PubMed Central

19 August 2017

Ali Rezaie

3

1 reference

Europe PubMed Central

19 August 2017

publication date

4 September 2008

1 reference

Europe PubMed Central

19 August 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

19 August 2017

54

1 reference

Europe PubMed Central

19 August 2017

6

1 reference

Europe PubMed Central

19 August 2017

1157-1170

1 reference

Europe PubMed Central

19 August 2017

https://scigraph.springernature.com/pub.10.1007/s10620-008-0481-x

0 references

Antibiotics and probiotics in treatment of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-008-0481-X

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1007%2FS10620-008-0481-X

21 January 2018

Different therapy for different types of ulcerative colitis in China

1 reference

https://api.crossref.org/works/10.1007%2FS10620-008-0481-X

21 January 2018

Mucosal flora in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of biotransformation of sulphasalazine in the colon epithelial Caco-2 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Operating characteristics of a rank correlation test for publication bias

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: evolving concepts in treatment and disease modification in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antioxidant properties of 5-aminosalicylic acid: potential mechanism for its protective effect in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in Antioxidant Power and Levels of Epidermal Growth Factor and Nitric Oxide in Saliva of Patients with Inflammatory Bowel Diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current therapeutic recommendations: infliximab for ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent understanding of IBD pathogenesis: implications for future therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salicylates for ulcerative colitis--their mode of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Study on the Correlations among Disease Activity Index and Salivary Transforming Growth Factor-beta1 and Nitric Oxide in Ulcerative Colitis Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Meta-Analysis of Antibiotic Therapy for Active Ulcerative Colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18770034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-008-0481-X

1 reference

Europe PubMed Central

19 August 2017

release_l6533hnqwnavnggt5bnqwso2s4

1 reference

https://api.fatcat.wiki/v0/release/l6533hnqwnavnggt5bnqwso2s4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37260395&oldid=1840260348"